Investigative Toxicology Lead
Takeda Pharmaceuticals
Boston Massachusetts UNITED STATES
Matt Wagoner leads the Global Investigatory Toxicology network for Takeda Pharmaceuticals, where their team applies microphysiological systems (MPS) to enable the detection and de-risking of toxicities early in the pipeline to help make safer medicines. Before Takeda, Matt led the mRNA safety strategy for AstraZeneca Pharmaceuticals, and worked to develop and deploy MPS tools in support of projects. In the academic arena, Matt co-teaches a drug discovery course at Simmons College in Boston. He received his bachelors in biochemistry from the University of Illinois Urbana Champaign, his PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison and completed his PostDoc work at AstraZeneca Pharmaceuticals.
None yet.